According to the Complaint, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation drugs for the treatment of cancer.

According to the Complaint, Ontrak, Inc. is a healthcare company that offers a Predict-RecommendEngage platform that organizes and automates healthcare data integration and analytics. A critical component of this platform are Ontrak programs, which are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions.

According to the Complaint, Renewable Energy Group, Inc. provides clean, low carbon transportation fuels. It is North America's largest producer of advanced biofuels.

According to the Complaint, provides solutions to develop safe automated systems including real-time surround view lidar sensors. The Company became a public entity on or about September 29, 2020 when it merged with Graf Industrial Corp., a special purpose acquisition company.

According to the Complaint, Aquestive Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing various products to address unmet medical needs. The Company's most advanced proprietary product candidate is Libervant (diazepam), a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures.

According to the Complaint, AgEagle Aerial Systems, Inc. purports to be a commercial drone company. According to AgEagle's website, the Company is engaged in the design, engineering, and manufacturing of commercial drones, as well as in providing drone services and solutions to the agriculture industry.

According to the Complaint, Infinity Q Capital Management, LLC is a registered investment advisor that purports to provide hedge fund strategies to institutional and retail investors. Infinity Q acts as investment advisor to the Infinity Q Diversified Alpha Fund (the "Fund"), pursuant to an Investment Advisory Agreement.
 

According to the Complaint, Churchill Capital Corp. III is a blank check company. In July 2020, Churchill III announced that it had entered into a preliminary agreement, subject to shareholder approval, to merge with MultiPlan Corporation. MultiPlan is a New York-based data analytics end-to-end cost management solutions provider to the U.S. healthcare industry. The merger was consummated in October 2020.

According to the Complaint, Sportsman's Warehouse Holdings, Inc. operates 103 stores across 27 states, including stores in Humboldt and Sonoma Counties, California. The Company is known for its top-quality, brand-name products, strong customer service and deep ties to conservation groups across the country.

According to the Complaint, Waddell & Reed Financial, Inc. has provided investment management and wealth management services to clients throughout the United States since 1937.

According to the Complaint, Apache Corporation is an independent energy company that explores for, develops, and produces natural gas, crude oil, and natural gas liquids. The U.S. has historically represented nearly 60% of the Company's production and 70% of its estimated year-end proved reserves. At all relevant times, one of the Company's purported key "core growth areas" in the U.S. was the Permian region, a large oil-and-gas producing area in West Texas and New Mexico.

According to the Complaint, Ebix, Inc. supplies infrastructure exchanges to the insurance, financial, travel, cash remittances, and healthcare industries.

According to the Complaint, Immunovant, Inc. is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of autoimmune diseases. On September 29, 2019, Health Sciences Acquisitions Corporation (“HSAC”), then a blank check company, or SPAC, entered into an agreement with Legacy Immunovant, a private biopharmaceutical company, and shareholders of Legacy Immunovant, to effect a merger between the two entities. As a result of the Merger, HSAC acquired all of the issued and outstanding shares of Legacy Immunovant, and Legacy Immunovant became a wholly owned subsidiary of HSAC. Upon the closing of the Merger, HSAC changed its name to “Immunovant, Inc.”

According to the Complaint, Virtual Multichannel Video Programming Distributors (“vMVPDs”), like Fubo, aggregate live and on-demand television content for delivery over the internet. Unlike traditional cable TV or satellite provider, Fubo does not supply its own data transport infrastructure (e.g., the cable) and instead relies on subscribers to maintain their own internet connection to access its service. vMVPDs offer service and product bundles to subscribers offering channels at a lower monthly rate than offered by traditional cable/satellite providers. There currently are 271 online video services vMVPDs that provide viewers with content from broadcast and cable network as well as streaming providers.

According to the Complaint, EHang Holdings Limited purports to be an autonomous aerial vehicle technology platform company engaged in “pioneering” the future of transportation through the Company’s purportedly proprietarily developed AAVs and related commercial solutions.

According to the Complaint, Jianpu Technology Inc. purports to be the leading independent open platform for discovery and recommendation of financial products in China. The Company touts its proprietary technology which provides search results and recommendations tailored to each user’s financial needs and credit profile.

Plaintiff files this action on behalf of all those individuals and entities who during the period of January 22, 2021 through February 2, 2021, (i) either (a) purchased GameStop shares (b) purchased back an option on GameStop shares, (c) had an option for GameStop shares called away from them, (d) purchased GameStop shares to cover a short position, or (e) had their options expire, and (ii) suffered losses as a result of any transactions identified by clauses (a)-(e) of the Complaint.

According to the Complaint, Nantkwest, Inc. is a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system to treat cancer and infectious diseases.

According to the Complaint, bluebird bio, Inc. is a biotechnology company that engages in researching, developing, and commercializing transformative gene therapies for severe genetic diseases and cancer. The Company’s gene therapy programs include, among others, LentiGlobin (bb1111) for the treatment of SCD. In May 2020, in the midst of the COVID-19 pandemic, bluebird announced that the Company expected to submit a BLA to the FDA for LentiGlobin for SCD in the second half of 2021.

According to the Complaint, Neos Therapeutics, Inc. is a pharmaceutical company that develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform.